Company Name:Fate Therapeutics Inc.
CEO: J. Scott Wolchko

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of programmed cellular immunotherapies for cancer and immune disorders.


Key numbers

Market Capitalization:1111217100
Shares Outstanding: 75593000
Float: 71859083.765
Next Earning Date:2020-03-13
TTm EPS: -1.3101
TTm Dividend Rate:
200 days moving average:17.41
50 days moving average: 15.48
One day percent Change: -2.07



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,